NCT04644770
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04644770
Title A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
City of Hope Duarte California 91010 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224 United States Details
University of Chicago Chicago Illinois 60637 United States Details
East Jefferson General Hospital Metairie Louisiana 70006 United States Details
Tulane University Hospital & Clinics New Orleans Louisiana 70112 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
XCancer Omaha / Urology Cancer Center Omaha Nebraska 68130 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
University of Utah Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field